FAS Wealth Partners’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13M	Buy	322,370 +12,352	+4%	+$462K	0.81%	31
2025 Q4	$10.8M	Buy	310,018 +1,700	+0.6%	+$134K	0.7%	35
2025 Q3	$25.6M	Buy	308,318 +5,889	+2%	+$426K	1.74%	12
2025 Q2	$22.2M	Buy	302,429 +2,166	+0.7%	+$157K	1.64%	12
2025 Q1	$34.3M	Sell	300,263 -8,944	-3%	-$544K	2.8%	8
2024 Q4	$15.6M	Sell	309,207 -6,542	-2%	-$343K	1.31%	17
2024 Q3	$14.6M	Sell	315,749 -23	-0%	-$817	1.16%	19
2024 Q2	$10.3M	Buy	315,772 +4,389	+1%	+$120K	0.89%	27
2024 Q1	$7.84M	Buy	311,383 +1,092	+0.4%	+$25.8K	0.7%	31
2023 Q4	$10.1M	Sell	310,291 -473	-0.2%	-$13K	0.96%	25
2023 Q3	$8.47M	Sell	310,764 -7	-0%	-$203	0.91%	23
2023 Q2	$6.91M	Buy	310,771 +5,745	+2%	+$132K	0.87%	24
2023 Q1	$6.61M	Sell	305,026 -1,250	-0.4%	-$27.4K	0.72%	31
2022 Q4	$6.22M	Buy	306,276 +6,700	+2%	+$168K	0.7%	33
2022 Q3	$7.68M	Sell	299,576 -204	-0.1%	-$5.46K	0.85%	25
2022 Q2	$7.13M	Buy	299,780 +10,155	+4%	+$221K	0.75%	27
2022 Q1	$6.52M	Buy	289,625 +4,283	+2%	+$91.1K	0.61%	30
2021 Q4	$5.65M	Sell	285,342 -300	-0.1%	-$6.09K	0.52%	33
2021 Q3	$5.62M	Buy	285,642 +3,680	+1%	+$77K	0.53%	31
2021 Q2	$6.2M	Buy	281,962 +45,921	+19%	+$1.02M	0.58%	28
2021 Q1	$5.62M	Buy	236,041 +14,996	+7%	+$400K	0.58%	32
2020 Q4	$5.78M	Buy	221,045 +5,415	+3%	+$114K	0.66%	31
2020 Q3	$3.75M	Buy	215,630 +18,490	+9%	+$295K	0.51%	37
2020 Q2	$3.32M	Sell	197,140 -5,357	-3%	-$75.3K	0.49%	40
2020 Q1	$2.41M	Buy	+202,497	New	+$2.51M	0.42%	45